So the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has decided to review and consolidate legislation on medicines in the UK, with the stated aim of making the whole thing simpler to wade through. A laudable aim, and one that more lawsmiths should bear in mind. I recall my law tutor at Stirling University commencing his dissection of a newly-passed Act with “The primary aim of the legislators in drafting this law was to make it as complex and incomprehensible as possible, and in this they succeeded admirably.”
